Literature DB >> 22407723

Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations.

Warren Denning1, Suvendu Das, Siqi Guo, Jun Xu, John C Kappes, Zdenek Hel.   

Abstract

Lentiviral vectors are widely used as effective gene-delivery vehicles. Optimization of the conditions for efficient lentiviral transduction is of a high importance for a variety of research applications. Presence of positively charged polycations reduces the electrostatic repulsion forces between a negatively charged cell and an approaching enveloped lentiviral particle resulting in an increase in the transduction efficiency. Although a variety of polycations are commonly used to enhance the transduction with retroviruses, the relative effect of various types of polycations on the efficiency of transduction and on the potential bias in the determination of titer of lentiviral vectors is not fully understood. Here, we present data suggesting that DEAE-dextran provides superior results in enhancing lentiviral transduction of most tested cell lines and primary cell cultures. Specific type and source of serum affects the efficiency of transduction of target cell populations. Non-specific binding of enhanced green fluorescent protein (EGFP)-containing membrane aggregates in the presence of DEAE-dextran does not significantly affect the determination of the titer of EGFP-expressing lentiviral vectors. In conclusion, various polycations and types of sera should be tested when optimizing lentiviral transduction of target cell populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22407723      PMCID: PMC3456965          DOI: 10.1007/s12033-012-9528-5

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  28 in total

1.  HIV-1 nuclear import: in search of a leader.

Authors:  M I Bukrinsky; O K Haffar
Journal:  Front Biosci       Date:  1999-10-15

2.  Separable mechanisms of attachment and cell uptake during retrovirus infection.

Authors:  S Sharma; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.

Authors:  E Vigna; L Naldini
Journal:  J Gene Med       Date:  2000 Sep-Oct       Impact factor: 4.565

4.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.

Authors:  K Toyoshima; P K Vogt
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

Review 6.  Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications.

Authors:  Pankaj Kumar; Chan Woon-Khiong
Journal:  Curr Gene Ther       Date:  2011-04       Impact factor: 4.391

7.  Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer.

Authors:  J M Le Doux; N Landazuri; M L Yarmush; J R Morgan
Journal:  Hum Gene Ther       Date:  2001-09-01       Impact factor: 5.695

8.  Small increases in pH enhance retroviral vector transduction efficiency of NIH-3T3 cells.

Authors:  Tor W Jensen; Yong Chen; William M Miller
Journal:  Biotechnol Prog       Date:  2003 Jan-Feb

9.  Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.

Authors:  Gregory Lizée; Monica I Gonzales; Suzanne L Topalian
Journal:  Hum Gene Ther       Date:  2004-04       Impact factor: 5.695

Review 10.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics.

Authors:  M A Kay; J C Glorioso; L Naldini
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

View more
  27 in total

1.  Effect of fetal bovine serum on foamy and lentiviral vector production.

Authors:  John M Powers; Grant D Trobridge
Journal:  Hum Gene Ther Methods       Date:  2013-08-28       Impact factor: 2.396

2.  Comparison of Lentiviral Packaging Mixes and Producer Cell Lines for RNAi Applications.

Authors:  Christian Albrecht; Stefanie Hosiner; Brigitte Tichy; Silke Aldrian; Stefan Hajdu; Sylvia Nürnberger
Journal:  Mol Biotechnol       Date:  2015-06       Impact factor: 2.695

3.  Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells.

Authors:  Arash Nanbakhsh; Brad Best; Matthew Riese; Sridhar Rao; Li Wang; Jeffrey Medin; Monica S Thakar; Subramaniam Malarkannan
Journal:  J Vis Exp       Date:  2018-01-15       Impact factor: 1.355

4.  The Superiority of Sucrose Cushion Centrifugation to Ultrafiltration and PEGylation in Generating High-Titer Lentivirus Particles and Transducing Stem Cells with Enhanced Efficiency.

Authors:  Mahdi Eskandarian Boroujeni; Mossa Gardaneh
Journal:  Mol Biotechnol       Date:  2018-03       Impact factor: 2.695

5.  Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.

Authors:  Sébastien A Felt; Gaith N Droby; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

6.  Lentiviral transduction of neuronal cells.

Authors:  Hassen S Wollebo; Baheru Woldemichaele; Martyn K White
Journal:  Methods Mol Biol       Date:  2013

7.  Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461.

Authors:  Tehmina Masud; Charles Soong; Hong Xu; Justina Biele; Saelin Bjornson; Steven McKinney; Samuel Aparicio
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

8.  LentiRILES, a miRNA-ON sensor system for monitoring the functionality of miRNA in cancer biology and therapy.

Authors:  Viorel Simion; Claire Loussouarn; Yoan Laurent; Loris Roncali; David Gosset; Flora Reverchon; Audrey Rousseau; Francisco Martin; Patrick Midoux; Chantal Pichon; Emmanuel Garcion; Patrick Baril
Journal:  RNA Biol       Date:  2021-09-27       Impact factor: 4.766

Review 9.  Delivery technologies to engineer natural killer cells for cancer immunotherapy.

Authors:  Rakan El-Mayta; Zijing Zhang; Alex G Hamilton; Michael J Mitchell
Journal:  Cancer Gene Ther       Date:  2021-04-22       Impact factor: 5.854

10.  Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity.

Authors:  Valerie Sapp; Aitor Aguirre; Gayatri Mainkar; Jeffrey Ding; Eric Adler; Ronglih Liao; Sonia Sharma; Mohit Jain
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.